860572P

C17 Mono-Sulfo Galactosyl(β) Ceramide (d18:1/17:0)

Avanti Research^™ - A Croda Brand 860572P, powder

• Synonym(e): 3-O-sulfo-D-galactosyl-β1-1′-N-heptadecanoyl-D-erythro-sphingosine (ammonium salt), (synthetic)
• Empirische Formel (Hill-System): C₄₁H₈₂N₂O₁₁S
• CAS-Nummer: 1246303-23-0
• Molekulargewicht: 811.16
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 1 mg (860572P-1mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 860572P
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](OS([O-])(=O)=O)[C@H]([C@H]1CO)O.[NH4+]
• InChI: 1S/C41H79NO11S.H3N/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37(45)42-34(35(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)33-51-41-39(47)40(53-54(48,49)50)38(46)36(32-43)52-41;/h28,30,34-36,38-41,43-44,46-47H,3-27,29,31-33H2,1-2H3,(H,42,45)(H,48,49,50);1H
• InChIKey: YMVAMOSEAIAACO-FDBYLCKRSA-N

Beschreibung

Anwendung

C17 Mono-Sulfo Galactosyl(β) Ceramide (d18:1/17:0) is suitable for use as one of the lipid standards for quantification of different phospholipids by flow injection analysis-tandem mass spectrometry (FIA-MS/MS) method.[1][2]

Biochem./physiol. Wirkung

C17 Mono-Sulfo Galactosyl(β) Ceramide (d18:1/12:0) is a non-physical sulfatide. Accumulation of sulfatide impairs the activity of arylsulfatase A enzyme, which in turn leads to the development of genetic disease, metachromatic leukodystrophy.[3]

Verpackung

5 mL Amber Glass Screw Cap Vial (860572P-1mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids